Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 09:00 save search
MoonFox Data: Luckin Coffee has successfully secured a dominant position in the market through rapid expansion and a broadening customer base
Published: 2024-03-14 (Crawled : 09:00) - prnewswire.com
JG | $3.14 0.0% 500
|
Technology Services
|
| O: 5.92%
H: 9.72%
C: 1.88%
rapid expansion market
Atos positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Outsourced Digital Workplace Services report
Published: 2024-03-14 (Crawled : 09:00) - globenewswire.com
IT | $451.06 0.18% 0.0% 280K
|
Commercial Services
|
| O: 0.06%
H: 0.42%
C: -1.69%
gartner services report workplace
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
Published: 2024-02-27 (Crawled : 09:00) - biospace.com/
PTCHF | $2.64 1.15% 19.97% 0
|
n/a
|
| O: -0.56%
H: 0.0%
C: -0.38%
AKLI | $0.248 3.77% 4.02% 150K
|
|
| O: -3.85%
H: 12.67%
C: 6.92%
japan positive endeavorrx adhd trial results
Grifols announces positive topline phase 3 fibrinogen clinical trial results
Published: 2024-02-14 (Crawled : 09:00) - globenewswire.com
GRFS | $6.39 -1.39% -1.25% 960K
|
Health Technology
|
| O: 0.48%
H: 3.08%
C: 2.85%
positive topline trial results
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | $13.54 1.05% 0.74% 190K
|
n/a
|
| O: 2.39%
H: 4.67%
C: 1.67%
KMDA | $5.18 1.57% 1.16% 11K
|
Health Technology
|
| O: -1.05%
H: 0.41%
C: -0.35%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: -0.11%
H: 0.7%
C: 0.65%
avt03 prolia biosimilar positive results study
Nasdaq European Markets sustains its strong position in the SME listings and sustainable debt market in 2023
Published: 2024-01-08 (Crawled : 09:00) - globenewswire.com
NDAQ | $61.5 0.67% 0.68% 2.3M
|
Finance
|
| O: 0.18%
H: 1.75%
C: 1.69%
nasdaq market
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®
Published: 2023-11-29 (Crawled : 09:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
bat2206 stelara biosimilar positive solutions results study
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-11-29 (Crawled : 09:00) - globenewswire.com
ALVO | $13.54 1.05% 0.74% 190K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
KMDA | $5.18 1.57% 1.16% 11K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
avt05 simponi biosimilar positive results study
Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA
Published: 2023-11-13 (Crawled : 09:00) - prnewswire.com
IGMS | $7.96 3.38% 3.14% 690K
|
Health Technology
|
| O: -0.67%
H: 4.02%
C: 3.79%
fda positive lenvima meeting response
Fortuna receives positive decision from Mexican Court which reinstates the San Jose Mine environmental impact authorization
Published: 2023-10-30 (Crawled : 09:00) - globenewswire.com
FSM | News | $4.64 -0.43% 0.22% 3.6M
|
Non-Energy Minerals
|
| O: 3.46%
H: 0.33%
C: -3.68%
authorization positive impact
European Medicines Agency Committee for Orphan Medicinal Products provides positive opinion on Calliditas' application for setanaxib in Alport syndrome
Published: 2023-10-05 (Crawled : 09:00) - prnewswire.com
CALT | $18.5 1.65% 1.62% 1K
|
Health Technology
|
| O: 7.01%
H: 0.0%
C: -4.91%
positive application
Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
Published: 2023-09-22 (Crawled : 09:00) - biospace.com/
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 2.01%
H: 0.2%
C: -0.79%
breast her2 cancer trial negative
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2023-07-21 (Crawled : 09:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
tepkinly abbvie chmp positive treatment
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2023-07-21 (Crawled : 09:00) - globenewswire.com
GNMSF | News | $290.34 0.23% 3.83% 1.2K
|
Health Technology
|
| O: -0.14%
H: 0.82%
C: -1.01%
GMAB | News | $28.47 -0.32% -0.32% 430K
|
Health Technology
|
| O: -0.22%
H: 0.92%
C: 0.56%
tepkinly abbvie chmp positive treatment
Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published: 2023-07-17 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: 0.05%
H: 1.33%
C: 0.38%
ALNY | $143.8 -1.55% -1.58% 400K
|
Health Technology
|
| O: 5.53%
H: 5.23%
C: -2.49%
disease alzheimer’s positive results
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
Published: 2023-06-09 (Crawled : 09:00) - biospace.com/
VRTX | $400.76 -1.03% -1.06% 810K
|
Health Technology
|
| O: 0.28%
H: 0.44%
C: 0.18%
CRSP | News 4 | $55.65 -1.35% -1.35% 790K
|
Health Technology
|
| O: 8.5%
H: 0.52%
C: -9.82%
disease association positive cell trials results
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
Published: 2023-05-26 (Crawled : 09:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 0.45%
H: 0.79%
C: -1.17%
covid-19 veklury chmp renal positive dialysis
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
Published: 2023-04-17 (Crawled : 09:00) - biospace.com/
RLFTF | $1.45 11.45% 390
|
n/a
|
| O: -2.91%
H: 6.0%
C: -1.0%
rlf-100 positive therapeutics
Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396
Published: 2023-03-28 (Crawled : 09:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
zp8396 pharma positive results phase 1
Positive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in children under 12 years of age with haemophilia A: Swedish Orphan Biovitrum AB
Published: 2023-03-02 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.76%
H: 1.58%
C: 1.58%
topline children haemophilia positive results study
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.